Why the study?
Does radiofrequency catheter ablation safely and effectively cure recurrent drug-refractory idiopathic left ventricular tachycardia in patients without structural heart disease?
Does radiofrequency catheter ablation safely and effectively cure recurrent drug-refractory idiopathic left ventricular tachycardia in patients without structural heart disease?
Radiofrequency catheter ablation is a safe and effective cure for idiopathic left ventricular tachycardia in patients without structural heart disease.
May support RF ablation for refractory ILVT; hypothesis-generating and should not yet change practice.
BACKGROUND: Radiofrequency (RF) catheter ablation is a safe and effective cure for many forms of supraventricular tachycardia. Its efficacy in the cure of right ventricular outflow tract tachycardia, and some forms of left ventricular tachycardia in patients with left ventricular dysfunction, has also been shown. In contrast limited data are available to assess the role of RF catheter ablation in treating idiopathic left ventricular tachycardia (ILVT), an unusual form of tachycardia occurring in patients without demonstrable heart disease. AIM: To examine the efficacy and safety of RF catheter ablation in patients with ILVT. METHODS: Three patients without structural heart disease and with recurrent drug-refractory ILVT (right bundle branch block and left axis morphology) underwent electrophysiologic study (EPS) to initiate and localise the site of origin of their VT. RF catheter ablation of the VT focus was performed, with success being defined as failure to reinduce VT during incremental infusion of isoprenaline. RESULTS: In all three patients VT was inducible by rapid right atrial pacing and/or programmed ventricular stimulation, and could be terminated by intravenous verapamil. RF catheter ablation was successful in all patients. The site of successful ablation was common to each patient and was localised to the infero-apical aspect of the left ventricular septum. It was characterised by the recording of the earliest presystolic "P' potential during both sinus rhythm and induced ILVT. No complications occurred during the procedure. During follow-up periods ranging from six to 12 months there were no symptomatic or documented episodes of recurrent ILVT. CONCLUSIONS: We conclude that ILVT can be safely and effectively cured by RF catheter ablation.
No takes yet. Share an insight, caveat, or question.
Hellestrand et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: